EFFECTS OF SULPIRIDE AND CHLORPROMAZINE ON AUTISTIC AND POSITIVE PSYCHOTIC SYMPTOMS IN SCHIZOPHRENIC-PATIENTS - RELATIONSHIP TO DRUG CONCENTRATIONS

被引:39
作者
ALFREDSSON, G [1 ]
HARNRYD, C [1 ]
WIESEL, FA [1 ]
机构
[1] KAROLINSKA INST, DEPT PSYCHIAT & PSYCHOL, S-10401 STOCKHOLM 60, SWEDEN
关键词
D O I
10.1007/BF00427315
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
Schizophrenic patients were treated with fixed doses of sulpiride (800 mg/day) or chlorpromazine (CPZ) (400 mg/day) during a period of 8 wk using a double-blind design. There were 25 patients in each group and all of them fulfilled the Research Diagnostic Criteria (RDC) for schizophrenia. Autistic and psychotic symptoms were rated with subscales developed from the Comprehensive Psychopathological Rating Scale (CPRS). Autistic symptoms were also rated with a subscale of the Nurse''s Observation Scale for Inpatient Evaluation (NOSIE). Sulpiride was superior to CPZ in reducing the autistic symptoms. Patients with low concentrations of sulpiride in serum had a better recovery rate from autistic symptoms than those with high concentrations. Both drugs reduced positive psychotic symptoms to the same degree.
引用
收藏
页码:8 / 13
页数:6
相关论文
共 19 条
[1]   MASS FRAGMENTOGRAPHIC METHOD FOR DETERMINATION OF CHLORPROMAZINE AND 2 OF ITS ACTIVE METABOLITES IN HUMAN-PLASMA AND CSF [J].
ALFREDSSON, G ;
WODEHELGODT, B ;
SEDVALL, G .
PSYCHOPHARMACOLOGY, 1976, 48 (02) :123-131
[2]   RELATIONSHIPS BETWEEN DRUG CONCENTRATIONS IN SERUM AND CSF, CLINICAL EFFECTS AND MONOAMINERGIC VARIABLES IN SCHIZOPHRENIC-PATIENTS TREATED WITH SULPIRIDE OR CHLORPROMAZINE [J].
ALFREDSSON, G ;
BJERKENSTEDT, L ;
EDMAN, G ;
HARNRYD, C ;
OXENSTIERNA, G ;
SEDVALL, G ;
WIESEL, FA .
ACTA PSYCHIATRICA SCANDINAVICA, 1984, 69 :49-74
[3]   QUANTITATIVE-ANALYSIS OF SULPIRIDE IN BODY-FLUIDS BY HIGH-PERFORMANCE LIQUID-CHROMATOGRAPHY WITH FLUORESCENCE DETECTION [J].
ALFREDSSON, G ;
SEDVALL, G ;
WIESEL, FA .
JOURNAL OF CHROMATOGRAPHY, 1979, 164 (02) :187-193
[4]  
ALFREDSSON G, 1984, PSYCHOPHARMACOLOGY
[5]  
ASBERG M, 1978, ACTA PSYCHIAT SCAND, P5
[6]  
Bleuler E., 1916, Lehrbuch fur Psychiatrie
[7]  
CASSANO GB, 1975, CURR THER RES CLIN E, V17, P189
[8]   CONTROLLED TRIAL OF SULPIRIDE IN CHRONIC-SCHIZOPHRENIC PATIENTS [J].
EDWARDS, JG ;
ALEXANDER, JR ;
ALEXANDER, MS ;
GORDON, A ;
ZUTCHI, T .
BRITISH JOURNAL OF PSYCHIATRY, 1980, 137 (DEC) :522-529
[9]  
ELIZUR A, 1975, CURR THER RES CLIN E, V18, P578
[10]   CLINICAL-NEUROLEPTIC STUDY OF N-[(1-ATHYL-PYRROLIDIN-2-YL)-METHYL]-2-METHOXY-5-SULFAMOYL-BENZAMID-NEUROLEPTIKUMS SULPIRID (DOGMATILR) IN ACUTE SCHIZOPHRENIA CASES [J].
HAASE, HJ ;
FLORU, L ;
ULRICH, F .
INTERNATIONAL PHARMACOPSYCHIATRY, 1974, 9 (02) :77-94